CD274 and non-small cell lung carcinoma: We found that mice treated with pemetrexed displayed a substantial increase in PD-L1 levels in the CL1-5 xenograft tumor (figure 1E), suggesting that pemetrexed may stimulate certain signaling(s) in NSCLC tumors that drive the upregulation of PD-L1.